【摘 要】
：
Hepatocellular carcinoma (HCC) is the fourth leading global cause of tumor-related mortality. HCC has a high prevalence in patients with chronic liver diseases,
【机 构】
：
Liver Transplantation Unit,King Faisal Specialist Hospital&Research Centre,Riyadh 12713,Saudi Arabia
论文部分内容阅读
Hepatocellular carcinoma (HCC) is the fourth leading global cause of tumor-related mortality. HCC has a high prevalence in patients with chronic liver diseases, and it mostly results from cirrhosis caused by infection with blood-borne viruses. Despite the implementation of various diagnostic and prevention strategies, the rates of new HCC cases and mortality are increasing globally due to the aging and growth of the world population as well as their increased exposure to dominant risk factors like alcohol, hepatitis B and C, and clinical correlates of metabolic syndrome. Modeling studies indicate that sanitation practices, implementation of vaccination programs against hepatitis B, and expanded recognition and treatment of patients with chronic hepatitis B and C could greatly contribute to the eradication of viral hepatitis B and C. While the availability of generic antiviral drugs could partially overcome the bottleneck represented by the lack of resources in low and middle-income countries, where viral hepatitis is the leading cause of liver cancer, the enthusiasm for the prevention of liver cancer through antiviral therapy is mitigated by the risk of cancer in many patients who are treated late in the hepatitis course. The present work aimed to review in detail the various types, epidemiology, and carcinogenesis mechanisms of viral infections that are associated with a significantly increased risk for the development of HCC.
其他文献
Hepatocellular carcinoma (HCC) is a poor prognosis tumor when not accessible to potentially curative treatments such as surgical resection, thermal ablations or
Aim: To test the efficacy and safety of liver stereotactic body radiation therapy (SBRT) in patients who harbor adverse factors. Methods: We retrospectively eva
Liver transplant (LT) is the curative treatment for patients with hepatocellular carcinoma (HCC). Bridge therapies are local treatments given to patients on the
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and usually arises in cirrhotic livers. Increasingly, it is diagnosed in non-cirrhotic li
Aim: To compare the phenotype of lean versus overweight (OW) and obese (OB) subjects with non-alcoholic fatty liver disease (NAFLD) across multiple continents.M
目的探讨爆炸伤救治培训课程的设计和实施中发现的问题。方法根据军队战伤救治卫勤救治链和爆炸伤伤员病情演变病理特点,我们设计了爆炸伤救治培训课程。采用巡回培训方式和理论授课、电视教学、实际案例分析和技能训练穿插进行的教学方法,于2019-09和2020-11先后进行了新疆呼图壁、甘肃兰州2站培训,通过课前课后讨论和测试评价培训效果。结果2站培训共培训学员272名,其中共有260名学员完成了课前测试并提交了有效答卷,204名学员完成课后测试并提交了有效答卷。课前测试学员成绩统计结果显示,大多数人(197人,占7
Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 25％ of the worldwide population, and is the leading cause of chronic liver disease in developed
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer-related death worldwide. Surgical resection is still regard
结蛋白肌病主要表现为下肢对称性远端肌无力，部分病例累及心肌和心脏传导系统。本文报道1例少见的结蛋白肌病病例，双侧心室心肌受累导致心力衰竭以及传导系统受累导致束支传导阻滞。
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases and is related to unhealthy lifestyle habits, characterized by a diet rich in